cxl-1020
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2009 (NCT01092325)
Timeline
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
CS(=O)(=O)c1ccccc1S(=O)(=O)NO- Mol. weight
- 251.28 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Prodrug
Sources
- ChEMBLCHEMBL4297464 ↗
Also known as
- cxl-1020
- cxl-1020
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01096043 | Phase 2 | Apr 1, 2010 | Boston University, Bristol-Myers Squibb, Cardioxyl Pharmaceuticals |
| NCT01092325 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2009 | Bristol-Myers Squibb, Cardioxyl Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bristol-Myers Squibb | For profit | 2 | 2 | 1 | 2009 |
| Cardioxyl Pharmaceuticals | For profit | 2 | 0 | 1 | 2009 |
| Boston University | Academic/Hospital | 1 | 0 | 1 | 2010 |
3 organizations
Page 1 / 1